Semin Plast Surg 2014; 28(4): 184-192
DOI: 10.1055/s-0034-1390171
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

An Update on Midface Advancement Using Le Fort II and III Distraction Osteogenesis

Youssef Tahiri
1   Division of Plastic and Reconstructive Surgery, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania
,
Jesse Taylor
1   Division of Plastic and Reconstructive Surgery, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania
› Author Affiliations
Further Information

Publication History

Publication Date:
04 November 2014 (online)

Abstract

Le Fort II and III distraction osteogenesis (DO) is a powerful tool in the craniofacial armamentarium that is most often employed to treat patients with craniofacial syndromes such as Crouzon, Apert, or Pfeiffer syndrome who present with midfacial retrusion, shallow orbits, exorbitism, malocclusion, obstructive sleep apnea and facial imbalance. In this article, the authors will provide the reader with an update on techniques for the treatment of various forms of midfacial retrusion.

 
  • References

  • 1 Tessier P. The classic reprint. Experimental study of fractures of the upper jaw. I and II. René Le Fort, M.D. Plast Reconstr Surg 1972; 50 (5) 497-506
  • 2 Tessier P. Syndrome de Crouzon, syndrome d'Apert: oxycéphalie, scaphocéphalies, turricéphalies. Ann Chir Plast 1967; 12 (4) 273-286
  • 3 Tessier P. Relationship of craniostenoses to craniofacial dysostoses, and to faciostenoses: a study with therapeutic implications. Plast Reconstr Surg 1971; 48 (3) 224-237
  • 4 Tessier P. Total osteotomy of the middle third of the face for faciostenosis or for sequelae of Le Fort 3 fractures. Plast Reconstr Surg 1971; 48 (6) 533-541
  • 5 Tessier P. The definitive plastic surgical treatment of the severe facial deformities of craniofacial dysostosis. Crouzon's and Apert's diseases. Plast Reconstr Surg 1971; 48 (5) 419-442
  • 6 Tessier P, Guiot G, Rougerie J, Delbet JP, Pastoriza J. Ostéotomies cranio-naso-orbito-faciales. Hypertelorism. Ann Chir Plast 1967; 12 (2) 103-118
  • 7 Gillies H, Harrison SH. Operative correction by osteotomy of recessed malar maxillary compound in a case of oxycephaly. Br J Plast Surg 1950; 3 (2) 123-127
  • 8 Gillies H, Millard R. The Principles and Art of Plastic Surgery. Boston, MA: Little, Brown and Company; 1957
  • 9 Cohen SR, Rutrick RE, Burstein FD. Distraction osteogenesis of the human craniofacial skeleton: initial experience with new distraction system. J Craniofac Surg 1995; 6 (5) 368-374
  • 10 Sándor GKB, Ylikontiola LP, Serlo W, Pirttiniemi PM, Carmichael RP. Midfacial distraction osteogenesis. Atlas Oral Maxillofac Surg Clin North Am 2008; 16 (2) 249-272
  • 11 Cedars MG, Linck II DL, Chin M, Toth BA. Advancement of the midface using distraction techniques. Plast Reconstr Surg 1999; 103 (2) 429-441
  • 12 Chin M, Toth BA. Le Fort III advancement with gradual distraction using internal devices. Plast Reconstr Surg 1997; 100 (4) 819-830 , discussion 831–832
  • 13 Fearon JA. The Le Fort III osteotomy: to distract or not to distract?. Plast Reconstr Surg 2001; 107 (5) 1091-1103 , discussion 1104–1106
  • 14 McCarthy JG, Stelnicki EJ, Mehrara BJ, Longaker MT. Distraction osteogenesis of the craniofacial skeleton. Plast Reconstr Surg 2001; 107 (7) 1812-1827
  • 15 Phillips JH, George AK, Tompson B. Le Fort III osteotomy or distraction osteogenesis imperfecta: your choice. Plast Reconstr Surg 2006; 117 (4) 1255-1260
  • 16 Swennen G, Schliephake H, Dempf R, Schierle H, Malevez C. Craniofacial distraction osteogenesis: a review of the literature: Part 1: clinical studies. Int J Oral Maxillofac Surg 2001; 30 (2) 89-103
  • 17 Cheung LK, Lo J. Distraction of Le Fort II osteotomy by intraoral distractor: a case report. J Oral Maxillofac Surg 2006; 64 (5) 856-860
  • 18 Fearon JA. Halo distraction of the Le Fort III in syndromic craniosynostosis: a long-term assessment. Plast Reconstr Surg 2005; 115 (6) 1524-1536
  • 19 Iannetti G, Fadda T, Agrillo A, Poladas G, Iannetti G, Filiaci F. LeFort III advancement with and without osteogenesis distraction. J Craniofac Surg 2006; 17 (3) 536-543
  • 20 McCarthy JG, Schreiber J, Karp N, Thorne CH, Grayson BH. Lengthening the human mandible by gradual distraction. Plast Reconstr Surg 1992; 89 (1) 1-8 , discussion 9–10
  • 21 Gosain AK. Plastic Surgery Educational Foundation DATA Committee. Distraction osteogenesis of the craniofacial skeleton. Plast Reconstr Surg 2001; 107 (1) 278-280
  • 22 Bradley JP, Gabbay JS, Taub PJ , et al. Monobloc advancement by distraction osteogenesis decreases morbidity and relapse. Plast Reconstr Surg 2006; 118 (7) 1585-1597
  • 23 Mofid MM, Manson PN, Robertson BC, Tufaro AP, Elias JJ, Vander Kolk CA. Craniofacial distraction osteogenesis: a review of 3278 cases. Plast Reconstr Surg 2001; 108 (5) 1103-1114 , discussion 1115–1117
  • 24 Steinhäuser EW. Variations of Le Fort II osteotomies for correction of midfacial deformities. J Maxillofac Surg 1980; 8 (4) 258-265
  • 25 Paliga JT, Goldstein JA, Storm PB, Taylor JA. Monobloc minus Le Fort II for single-stage treatment of the Apert phenotype. J Craniofac Surg 2013; 24 (4) 1380-1382
  • 26 Watanabe K, Kuroda S, Takahashi T , et al. Segmental distraction osteogenesis with modified LeFort II osteotomy for a patient with craniosynostosis. Am J Orthod Dentofacial Orthop 2012; 142 (5) 698-709
  • 27 Nout E, Cesteleyn LLM, van der Wal KGH, van Adrichem LNA, Mathijssen IMJ, Wolvius EB. Advancement of the midface, from conventional Le Fort III osteotomy to Le Fort III distraction: review of the literature. Int J Oral Maxillofac Surg 2008; 37 (9) 781-789
  • 28 Fearon JA, Whitaker LA. Complications with facial advancement: a comparison between the Le Fort III and monobloc advancements. Plast Reconstr Surg 1993; 91 (6) 990-995
  • 29 Hopper RA, Kapadia H, Morton T. Normalizing facial ratios in apert syndrome patients with Le Fort II midface distraction and simultaneous zygomatic repositioning. Plast Reconstr Surg 2013; 132 (1) 129-140
  • 30 Ranly DM. Craniofacial growth. Dent Clin North Am 2000; 44 (3) 457-470 , v
  • 31 Posnick JC. The craniofacial dysostosis syndromes. Staging of reconstruction and management of secondary deformities. Clin Plast Surg 1997; 24 (3) 429-446
  • 32 Bachmayer DI, Ross RB, Munro IR. Maxillary growth following LeFort III advancement surgery in Crouzon, Apert, and Pfeiffer syndromes. Am J Orthod Dentofacial Orthop 1986; 90 (5) 420-430
  • 33 Kreiborg S, Aduss H. Pre- and postsurgical facial growth in patients with Crouzon's and Apert's syndromes. Cleft Palate J 1986; 23 (Suppl. 01) 78-90
  • 34 Meazzini MC, Mazzoleni F, Caronni E, Bozzetti A. Le Fort III advancement osteotomy in the growing child affected by Crouzon's and Apert's syndromes: presurgical and postsurgical growth. J Craniofac Surg 2005; 16 (3) 369-377
  • 35 Fearon JA, Patel N. Abstract 1: Treatment of the syndromic mid face with rigid external distraction Le Fort III: a long-term assessment at skeletal maturity. Plast Reconstr Surg 2014; 133 (4, Suppl) 973
  • 36 Cohen SR, Holmes RE. Internal Le Fort III distraction with biodegradable devices. J Craniofac Surg 2001; 12 (3) 264-272
  • 37 Burstein FD, Williams JK, Hudgins R , et al. Single-stage craniofacial distraction using resorbable devices. J Craniofac Surg 2002; 13 (6) 776-782
  • 38 Polley JW, Figueroa AA. Management of severe maxillary deficiency in childhood and adolescence through distraction osteogenesis with an external, adjustable, rigid distraction device. J Craniofac Surg 1997; 8 (3) 181-185 , discussion 186
  • 39 Gosain AK, Santoro TD, Havlik RJ, Cohen SR, Holmes RE. Midface distraction following Le Fort III and monobloc osteotomies: problems and solutions. Plast Reconstr Surg 2002; 109 (6) 1797-1808
  • 40 Freihofer Jr HP. Results after midface-osteotomies. J Maxillofac Surg 1973; 1 (1) 30-36
  • 41 Girotto JA, Davidson J, Wheatly M , et al. Blindness as a complication of Le Fort osteotomies: role of atypical fracture patterns and distortion of the optic canal. Plast Reconstr Surg 1998; 102 (5) 1409-1421 , discussion 1422–1423
  • 42 McCarthy JG, La Trenta GS, Breitbart AS, Grayson BH, Bookstein FL. The Le Fort III advancement osteotomy in the child under 7 years of age. Plast Reconstr Surg 1990; 86 (4) 633-646 , discussion 647–649
  • 43 Matsumoto K, Nakanishi H, Seike T, Koizumi Y, Hirabayashi S. Intracranial hemorrhage resulting from skull base fracture as a complication of Le Fort III osteotomy. J Craniofac Surg 2003; 14 (4) 545-548
  • 44 Nout E, Wolvius EB, van Adrichem LN, Ongkosuwito EM, van der Wal KG. Complications in maxillary distraction using the RED II device: a retrospective analysis of 21 patients. Int J Oral Maxillofac Surg 2006; 35 (10) 897-902
  • 45 Holmes AD, Wright GW, Meara JG, Heggie AA, Probert TC. LeFort III internal distraction in syndromic craniosynostosis. J Craniofac Surg 2002; 13 (2) 262-272
  • 46 Brown R, Higuera S, Boyd V, Taylor T, Hollier Jr LH. Intracranial migration of a halo pin during distraction osteogenesis for maxillary hypoplasia: case report and literature review. J Oral Maxillofac Surg 2006; 64 (1) 130-135
  • 47 Le BT, Eyre JM, Wehby MC, Wheatley MJ. Intracranial migration of halo fixation pins: a complication of using an extraoral distraction device. Cleft Palate Craniofac J 2001; 38 (4) 401-404
  • 48 Saltaji H, Altalibi M, Major MP , et al. Le Fort III distraction osteogenesis versus conventional Le Fort III osteotomy in correction of syndromic midfacial hypoplasia: a systematic review. J Oral Maxillofac Surg 2014; 72 (5) 959-972
  • 49 Shetye PR, Kapadia H, Grayson BH, McCarthy JG. A 10-year study of skeletal stability and growth of the midface following Le Fort III advancement in syndromic craniosynostosis. Plast Reconstr Surg 2010; 126 (3) 973-981
  • 50 Warren SM, Shetye PR, Obaid SI, Grayson BH, McCarthy JG. Long-term evaluation of midface position after Le Fort III advancement: a 20-plus-year follow-up. Plast Reconstr Surg 2012; 129 (1) 234-242
  • 51 Shetye PR, Davidson EH, Sorkin M, Grayson BH, McCarthy JG. Evaluation of three surgical techniques for advancement of the midface in growing children with syndromic craniosynostosis. Plast Reconstr Surg 2010; 126 (3) 982-994
  • 52 Iannetti G, Ramieri V, Pagnoni M, Fadda MT, Cascone P. Le Fort III external midface distraction: surgical outcomes and skeletal stability. J Craniofac Surg 2012; 23 (3) 896-900
  • 53 Figueroa AA, Polley JW, Friede H, Ko EW. Long-term skeletal stability after maxillary advancement with distraction osteogenesis using a rigid external distraction device in cleft maxillary deformities. Plast Reconstr Surg 2004; 114 (6) 1382-1392 , discussion 1393–1394
  • 54 Chin M, Toth BA. Distraction osteogenesis in maxillofacial surgery using internal devices: review of five cases. J Oral Maxillofac Surg 1996; 54 (1) 45-53 , discussion 54
  • 55 Fearon JA. Le Fort III osteotomy or distraction osteogenesis imperfecta. Plast Reconstr Surg 2007; 119 (3) 1122-1123
  • 56 David DJ, Sheen R. Surgical correction of Crouzon syndrome. Plast Reconstr Surg 1990; 85 (3) 344-354
  • 57 Epker BN, Wolford LM. Middle-third facial osteotomies: their use in the correction of congenital dentofacial and craniofacial deformities. J Oral Surg 1976; 34 (4) 324-342
  • 58 Kaban LB, Conover M, Mulliken JB. Midface position after Le Fort III advancement: a long-term follow-up study. Cleft Palate J 1986; 23 (Suppl. 01) 75-77
  • 59 Seruya M, Borsuk DE, Khalifian S, Carson BS, Dalesio NM, Dorafshar AH. Computer-aided design and manufacturing in craniosynostosis surgery. J Craniofac Surg 2013; 24 (4) 1100-1105
  • 60 Mommaerts MY, Jans G, Vander Sloten J, Staels PF, Van der Perre G, Gobin R. On the assets of CAD planning for craniosynostosis surgery. J Craniofac Surg 2001; 12 (6) 547-554
  • 61 Makhdom AM, Hamdy RC. The role of growth factors on acceleration of bone regeneration during distraction osteogenesis. Tissue Eng Part B Rev 2013; 19 (5) 442-453
  • 62 Farberg AS, Sarhaddi D, Donneys A, Deshpande SS, Buchman SR. Deferoxamine enhances bone regeneration in mandibular distraction osteogenesis. Plast Reconstr Surg 2014; 133 (3) 666-671
  • 63 Donneys A, Deshpande SS, Tchanque-Fossuo CN , et al. Deferoxamine expedites consolidation during mandibular distraction osteogenesis. Bone 2013; 55 (2) 384-390
  • 64 Wu GP, He XC, Hu CB, Li DP, Yang ZH, Guo L. Effect of electroporation-mediated transfecting recombinant plasmid pIRES-hBMP2-hVEGF165 on mandibular distraction osteogenesis. Ann Plast Surg 2012; 69 (3) 316-325
  • 65 Eguchi Y, Wakitani S, Naka Y, Nakamura H, Takaoka K. An injectable composite material containing bone morphogenetic protein-2 shortens the period of distraction osteogenesis in vivo. J Orthop Res 2011; 29 (3) 452-456
  • 66 Sailhan F, Gleyzolle B, Parot R, Guerini H, Viguier E. Rh-BMP-2 in distraction osteogenesis: dose effect and premature consolidation. Injury 2010; 41 (7) 680-686